- Home
- KAI vs RNA Comparison
KAI vs RNA Comparison
Compare KAI & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAI
- RNA
- Stock Information
- Founded
- KAI 1991
- RNA 2012
- Country
- KAI United States
- RNA United States
- Employees
- KAI N/A
- RNA N/A
- Industry
- KAI Industrial Machinery/Components
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- KAI Industrials
- RNA Health Care
- Exchange
- KAI Nasdaq
- RNA Nasdaq
- Market Cap
- KAI 3.8B
- RNA 4.0B
- IPO Year
- KAI N/A
- RNA 2020
- Fundamental
- Price
- KAI $357.98
- RNA $36.88
- Analyst Decision
- KAI Buy
- RNA Strong Buy
- Analyst Count
- KAI 2
- RNA 14
- Target Price
- KAI $327.50
- RNA $67.71
- AVG Volume (30 Days)
- KAI 105.7K
- RNA 2.6M
- Earning Date
- KAI 07-29-2025
- RNA 08-08-2025
- Dividend Yield
- KAI 0.38%
- RNA N/A
- EPS Growth
- KAI N/A
- RNA N/A
- EPS
- KAI 8.98
- RNA N/A
- Revenue
- KAI $1,024,121,000.00
- RNA $8,927,000.00
- Revenue This Year
- KAI N/A
- RNA N/A
- Revenue Next Year
- KAI $4.52
- RNA $196.18
- P/E Ratio
- KAI $39.86
- RNA N/A
- Revenue Growth
- KAI 1.74
- RNA N/A
- 52 Week Low
- KAI $281.30
- RNA $21.51
- 52 Week High
- KAI $429.95
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- KAI 67.07
- RNA 65.42
- Support Level
- KAI $340.35
- RNA $34.25
- Resistance Level
- KAI $343.86
- RNA $37.59
- Average True Range (ATR)
- KAI 9.68
- RNA 2.08
- MACD
- KAI 2.21
- RNA 0.40
- Stochastic Oscillator
- KAI 78.42
- RNA 74.58
About KAI Kadant Inc
Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.